Sarepta Therapeutics

Filed a patent for "non-canonical cell-penetrating peptides for antisense oligonucleotide delivery" on Wed, August 2, 2023

Filed a patent for "raav production methods" on Wed, February 1, 2023

Filed a patent for "raav production methods" on Tue, February 28, 2023

Filed a patent for "antisense oligomers for treatment of adtkd-umod" on Thu, April 27, 2023

Filed a patent for "fusion proteins comprising cas enzymes and dna-binding proteins" on Tue, May 16, 2023

Filed a patent for "systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy" on Thu, November 14, 2024

Filed a patent for "gene therapy for angelman syndrome" on Wed, February 8, 2023

Filed a patent for "dmd antisense oligonucleotide-mediated exon skipping efficiency" on Wed, September 21, 2022

Filed a patent for "recombinant aav vectors for treating muscular dystrophy" on Fri, September 23, 2022

Filed a patent for "pompe disease mouse model generation, characterization and methods of use" on Wed, September 28, 2022

Filed a patent for "exon skipping oligomer conjugates for muscular dystrophy" on Thu, February 8, 2024

Filed a patent for "methods of treating muscular dystrophy" on Wed, November 2, 2022

Filed a patent for "formulation of an antisense oligomer conjugate" on Wed, November 2, 2022

Filed a patent for "recombinant aav vectors for treating muscular dystrophy" on Mon, February 27, 2023

Filed a patent for "peptide oligonucleotide conjugates" on Thu, October 5, 2023

Filed a patent for "recombinant aav vectors for treating muscular dystrophy" on Tue, June 20, 2023

Filed a patent for "recombinant aav vectors for treating muscular dystrophy" on Mon, August 7, 2023

Filed a patent for "morpholino oligomers for treatment of peripheral myelin protein 22 related diseases" on Fri, April 19, 2024

Filed a patent for "exon skipping oligomer conjugates for muscular dystrophy" on Thu, April 13, 2023

Filed a patent for "compositions and methods for restoring and maintaining the dystrophin-associated protein complex (dapc)" on Thu, February 9, 2023

Filed a patent for "methods of treating muscular dystrophy" on Thu, June 30, 2022

Filed a patent for "antisense oligonucleotides having one or more abasic units" on Tue, September 20, 2022

Filed a patent for "morpholino oligomers for treatment of peripheral myelin protein 22 related diseases" on Mon, September 26, 2022